Oxford BioMedica (United Kingdom)

Oxford BioMedica (United Kingdom)

Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Oxford BioMedica (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

82%


Total
Publications

3.9K


Total Open
Publications

3.2K


Total
Citations

170K


Open Access
Percentage

82%


Total
Publications

3.9K


Total Open
Publications

3.2K


Total
Citations

170K

Wikipedia

Website

download

Breakdown

12% 52% 18% 18%

Publisher Open

12%

Both

52%

Other Platform Open

18%

Closed

18%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300350400450500550Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

905

Hybrid 44%

1.1K

No Guarantees 20%

501

Other Platform Open

Institution 69%

1.9K

Domain 65%

1.8K

Other Internet 15%

408

Preprint 14%

387

Public 6%

156

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
1.8K
University of Oxford - Oxford University Research Archive (ORA)
Institution
1.2K
Europe PMC
Domain
660
University College London - UCL Discovery
Institution
476
DOI
Other Internet
331
University of Edinburgh - Edinburgh Research Explorer
Institution
207
University of Cambridge - Apollo
Institution
205
University of Bristol - Bristol Research
Institution
193
bioRxiv
Preprint
181
University of Southampton - ePrints Soton
Institution
180
1 / 20

Data updated 7 April 2025

Share

Share

Share